# Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment With Fluvoxamine

> **NCT02016261** · PHASE4 · COMPLETED · sponsor: **Moscow Research Institute of Psychiatry** · enrollment: 50 (actual)

## Conditions studied

- Recurrent Depressive Disorder

## Interventions

- **DRUG:** Fluvoxamine

## Key facts

- **NCT ID:** NCT02016261
- **Lead sponsor:** Moscow Research Institute of Psychiatry
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02016261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02016261, "Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment With Fluvoxamine". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02016261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*